How to read a hepatitis B five-item blood test report
The results of the hepatitis B panel test are primarily interpreted by determining whether the values are positive or negative relative to the reference range, thereby assessing whether a patient has a hepatitis B virus infection. The specific analysis is as follows:
The hepatitis B panel includes five components: hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs), hepatitis B e-antigen (HBeAg), hepatitis B e-antibody (anti-HBe), and hepatitis B core antibody (anti-HBc). Testing these five markers helps determine an individual's risk of hepatitis B infection, the timing of infection, and the level of disease activity. It provides valuable information for clinical diagnosis and monitoring treatment effectiveness. The primary cause of abnormal hepatitis B panel results is hepatitis B virus infection; this test can reveal both the extent and duration of the infection. Additionally, abnormalities may also result from immune system deficiencies, abnormal autoimmune responses, or other liver conditions such as cirrhosis and fatty liver disease.
In summary, the hepatitis B panel plays a crucial role in diagnosing hepatitis B infection and managing the disease clinically. Individuals with abnormal test results should seek timely medical evaluation for accurate diagnosis and appropriate treatment. Furthermore, preventive measures—such as receiving the hepatitis B vaccine, avoiding excessive fatigue, and refraining from inappropriate use of medications—can help prevent abnormalities in the hepatitis B panel.